Manfidokimab (AK120) is a human monoclonal antibody of the IgG4 subclass that specifically targets the interleukin-4 receptor alpha subunit (IL-4Ralpha). by binding to this shared subunit, Manfidokimab simultaneously blocks the downstream signaling pathways of both interleukin-4 (IL-4) and interleukin-13 (IL-13), and Manfidokimab can be used in studies about moderate to severe atopic dermatitis.
Purity:
95%
CAS Number:
[2428381-56-8]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
